Blair William & CO Ginkgo Bioworks Holdings, Inc. Transaction History

Blair William & CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.28 - $1.16 $803 - $3,329	2,870 Added 9.53%	33,000 $10,000
Q1 2024 May 09, 2024	BUY	$1.06 - $1.67 $1,855 - $2,922	1,750 Added 6.17%	30,130 $34,000
Q4 2023 Feb 12, 2024	SELL	$1.26 - $1.79 $4,208 - $5,978	-3,340 Reduced 10.53%	28,380 $47,000
Q3 2023 Nov 09, 2023	SELL	$1.61 - $2.54 $3,059 - $4,826	-1,900 Reduced 5.65%	31,720 $57,000
Q2 2023 Aug 11, 2023	SELL	$1.14 - $1.95 $1,216 - $2,080	-1,067 Reduced 3.08%	33,620 $62,000
Q4 2022 Feb 10, 2023	SELL	$1.63 - $3.52 $10,546 - $22,774	-6,470 Reduced 15.72%	34,687 $58,000
Q3 2022 Nov 09, 2022	BUY	$0.73 - $3.74 $6,312 - $32,339	8,647 Added 26.6%	41,157 $128,000
Q2 2022 Aug 10, 2022	SELL	$2.2 - $4.2 $13,142 - $25,090	-5,974 Reduced 15.52%	32,510 $77,000
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $51,172 - $157,132	18,082 Added 88.63%	38,484 $155,000
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $169,540 - $304,397	20,402 New	20,402 $170,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.